COVID-19 and business continuity

We would like to reassure you that it is business as usual and provide an update regarding our response to the outbreak of the COVID-19 virus as well as our commitment to serving you and your critically important work moving forward.

Here are the measures that the Intelligent Tissue Group, comprising Tissue Solutions Ltd and HistologiX Ltd, is implementing relating to the COVID-19 outbreak to ensure the business continues uninterrupted.

Our top priorities are to continue running client projects without disruption, along with protecting the wellbeing and health of our staff.  While we continue to be fully operational and sample acquisition has not yet been affected, we are aware that circumstances may arise that impact on our collection rates and overall availability of human biomaterials.  We will continue to monitor this and we will be providing frequent updates through our website and our social media channels.

As a response to the developing situation we have made some changes to our normal practices and put in place contingency plans to allow further changes if they are required.

These changes include:

  • Replacing client visits and conference attendant to virtual meetings
  • Work-from-home initiatives where possible
  • Implementation of a shift pattern for lab-based staff
  • Encouraging staff to minimise all travel during this period
  • Following the Public Health Policy and government advice to ensure we comply with changing regulations as they happen.
  • Monitoring our extensive network of collection sites for changes in their operations

Our companies are well prepared, our IT infrastructure and processes are robust and we are well positioned to adapt our workflows to minimise the impact of the current situation.  Our goal is to provide uninterrupted levels of support to our clients during this period of uncertainty.

We encourage you to reach out to your business development representative or our customer service team at info@histologix.co.uk as questions or potential changes to your requirements arise. They are here and ready to help!

Finally, our thoughts go out to all those affected by COVID-19, and we extend our thanks to researchers who are working to develop new diagnostics, therapies, and vaccines, as well as those who are helping to directly care for patients in this difficult time.

Please connect with our social media channels as we will provide daily updates there.

Many thanks for your understanding and please stay safe.